Novo Nordisk’s (NVO) largest shareholder is taking control of the drugmaker’s board, with plans to revive sales growth of Wegovy in US market through mass-market channels, Reuters’ Bhanvi Satija and Maggie Fick report. Lars Rebien Sorensen, a former Novo CEO and the board’s new chairman, says the prior board was too slow to recognize the shift in the market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk Stock (NVO) Falls as Chair and Six Members Quit Board
- Mixed options sentiment in Novo Nordisk with shares down 1.44%
- Midday Fly By: GM, Coca-Cola report Q3 beats
- Novo Nordisk chairman, independent directors to step down, FT reports
- Novo Nordisk to Convene Extraordinary General Meeting for Board Election